Nutex Health raises $10M via 66.7M share/warrant offering at $0.15/unit

Nutex Health Inc.

Offering of 66.7M shares and warrants on a 1:1 basis at $0.15 per unit; gross proceeds ~$10M.
Closing expected Jan 25, 2024; Maxim Group LLC acts as placement agent with 7% fee.
Net proceeds for working capital, hospital facility development, and IPA expansion.
Warrants exercisable at $0.15 for 5 years; beneficial ownership cap of 4.99% (or 9.99% at holder's election).
Risk factors updated: warns of need for additional capital, potential hospital closures, and NSA reimbursement declines.

item 1.01 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.95

Nutex Health Inc. entered into Placement Agency Agreement with Maxim Group LLC (effective 2024-01-22).

Action: entry
Agreement: underwriting
Counterparty: Maxim Group LLC
Effective: 2024-01-22

Exact text from the filing

On January 22, 2024, the Company entered into a placement agency agreement with Maxim Group LLC (the “Placement Agent”) (the “Placement Agency Agreement”), pursuant to which the Company has agreed to pay the Placement Agent an aggregate fee equal to 7% of the aggregate gross proceeds received by the Company from the sale of the Shares and Warrants in the offering.

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.97

Nutex Health Inc. entered into Securities Purchase Agreement with a single healthcare focused institutional investor valued at approximately $10 million (effective 2024-01-22).

Action: entry
Agreement: equity purchase
Counterparty: a single healthcare focused institutional investor
Value: approximately $10 million
Effective: 2024-01-22

Exact text from the filing

On January 22, 2024, Nutex Health Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with a single healthcare focused institutional investor for the sale by the Company of 66,666,666 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share, and warrants (the “Warrants”) to purchase 66,666,666 shares of the Company’s common stock.

View on SEC.gov

Browse all material agreements →

Nutex Health Inc. filing history →

Source: SEC EDGAR

accession 0001104659-24-006283

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.